TD Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-46,874
| Closed | -$1.29M | – | 1424 |
|
2023
Q4 | $1.29M | Sell |
46,874
-12,200
| -21% | -$336K | ﹤0.01% | 1123 |
|
2023
Q3 | $1.32M | Sell |
59,074
-7,563
| -11% | -$169K | ﹤0.01% | 1074 |
|
2023
Q2 | $2.71M | Buy |
66,637
+26,386
| +66% | +$1.07M | ﹤0.01% | 884 |
|
2023
Q1 | $1.95M | Buy |
40,251
+21,354
| +113% | +$1.03M | ﹤0.01% | 994 |
|
2022
Q4 | $721K | Sell |
18,897
-13,316
| -41% | -$508K | ﹤0.01% | 1206 |
|
2022
Q3 | $1.62M | Buy |
32,213
+900
| +3% | +$45.3K | ﹤0.01% | 1071 |
|
2022
Q2 | $1.25M | Sell |
31,313
-4,801
| -13% | -$192K | ﹤0.01% | 1137 |
|
2022
Q1 | $1.35M | Sell |
36,114
-10,320
| -22% | -$385K | ﹤0.01% | 1182 |
|
2021
Q4 | $1.85M | Buy |
46,434
+4,518
| +11% | +$180K | ﹤0.01% | 1150 |
|
2021
Q3 | $1.56M | Hold |
41,916
| – | – | ﹤0.01% | 1150 |
|
2021
Q2 | $1.61M | Sell |
41,916
-1,889
| -4% | -$72.4K | ﹤0.01% | 1157 |
|
2021
Q1 | $2.07M | Buy |
43,805
+2,000
| +5% | +$94.7K | ﹤0.01% | 1093 |
|
2020
Q4 | $2.55M | Buy |
41,805
+2,307
| +6% | +$141K | ﹤0.01% | 969 |
|
2020
Q3 | $1.85M | Sell |
39,498
-1,900
| -5% | -$88.8K | ﹤0.01% | 929 |
|
2020
Q2 | $2.1M | Buy |
41,398
+11,600
| +39% | +$589K | ﹤0.01% | 868 |
|
2020
Q1 | $1.33M | Sell |
29,798
-49,833
| -63% | -$2.22M | ﹤0.01% | 927 |
|
2019
Q4 | $3.83M | Sell |
79,631
-3,025
| -4% | -$145K | 0.01% | 775 |
|
2019
Q3 | $2.8M | Buy |
82,656
+625
| +0.8% | +$21.1K | ﹤0.01% | 830 |
|
2019
Q2 | $3.69M | Buy |
82,031
+3,000
| +4% | +$135K | 0.01% | 764 |
|
2019
Q1 | $2.98M | Buy |
79,031
+12,600
| +19% | +$474K | ﹤0.01% | 824 |
|
2018
Q4 | $2.28M | Buy |
66,431
+10,000
| +18% | +$343K | ﹤0.01% | 883 |
|
2018
Q3 | $2.65M | Buy |
56,431
+41,600
| +280% | +$1.96M | ﹤0.01% | 928 |
|
2018
Q2 | $500K | Buy |
+14,831
| New | +$500K | ﹤0.01% | 1262 |
|